ArticleThe Prostate2026

Evaluating Risk Factors Associating With Late Recurrence After Low-Dose-Rate Brachytherapy for Prostate Cancer Using Machine Learning.

Kenta Onishi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.